Strata Skin Sciences Stock In The News

SSKN Stock  USD 1.88  0.07  3.87%   
Our overall analysis of STRATA Skin's news coverage and content from conventional and social sources shows investors' bearish mood towards STRATA Skin Sciences. The specific impact of STRATA Skin news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of STRATA Skin's overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using STRATA Skin headlines in addition to utilizing other, more conventional financial analysis modules. Check out STRATA Skin Backtesting and STRATA Skin Hype Analysis.

STRATA Skin Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
STRATA Skin Sciences Moves to Accelerate...
https://www.globenewswire.com/news-release/2025/08/07/3129238/23161/en/STRATA-Skin-Sciences-Moves-to-Accelerate-Medicare-and-Private-Payer-Coverage-from-Expanded-CPT-Code-Expansion-Tripling-Addressable-Market-to-30M-Patients.html
 Neutral
Macroaxis News: globenewswire.com
STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update
https://www.globenewswire.com/news-release/2025/07/31/3124972/23161/en/STRATA-Skin-Sciences-to-Report-Second-Quarter-2025-Financial-Results-on-August-13-2025-and-Provide-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
https://www.globenewswire.com/news-release/2025/05/14/3081575/23161/en/STRATA-Skin-Sciences-Reports-First-Quarter-2025-Financial-Results-and-Provides-a-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference
https://www.globenewswire.com/news-release/2025/05/08/3077237/23161/en/STRATA-Skin-Sciences-to-Participate-in-the-D-Boral-Capital-Inaugural-Global-Conference.html
 Neutral
Macroaxis News: globenewswire.com
STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update
https://www.globenewswire.com/news-release/2025/05/07/3076107/23161/en/STRATA-Skin-Sciences-to-Report-First-Quarter-2025-Financial-Results-on-May-14-2025-and-Provide-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update
https://www.globenewswire.com/news-release/2025/03/27/3050989/23161/en/STRATA-Skin-Sciences-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-a-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
STRATA Skin Sciences to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 and Provide Corporate Update
https://www.globenewswire.com/news-release/2025/03/21/3047272/23161/en/STRATA-Skin-Sciences-to-Report-Fourth-Quarter-and-Year-End-2024-Financial-Results-on-March-27-2025-and-Provide-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
STRATA Skin Sciences Highlights New Clin...
https://www.globenewswire.com/news-release/2025/03/20/3046204/23161/en/STRATA-Skin-Sciences-Highlights-New-Clinical-Study-from-Japan-Demonstrating-Superiority-of-Narrow-Band-Excimer-Laser-Over-Non-Narrow-Band-UVB-Source-Like-Excimer-Light.html
 Bullish
Macroaxis News: globenewswire.com
STRATA Skin Sciences Reports Third Quarter 2023 Revenue
https://www.globenewswire.com/news-release/2023/11/14/2780469/23161/en/STRATA-Skin-Sciences-Reports-Third-Quarter-2023-Revenue.html
 Neutral
Macroaxis News: globenewswire.com
STRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
https://www.globenewswire.com/news-release/2023/11/02/2772215/23161/en/STRATA-Skin-Sciences-to-Report-Third-Quarter-2023-Financial-Results-on-November-14-2023.html
 Bullish

STRATA Skin Sciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide STRATA and other traded companies coverage with news coverage. We help investors stay connected with STRATA headlines for the 13th of August 2025 to make an informed investment decision based on correlating the impacts of news items on STRATA Stock performance. Please note that trading solely based on the STRATA Skin Sciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
STRATA Skin's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help STRATA Skin Sciences investors visualize upcoming and past events in order to time the market based on STRATA Skin Sciences noise-free hype analysis.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards STRATA Skin in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, STRATA Skin's short interest history, or implied volatility extrapolated from STRATA Skin options trading.
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.27)
Revenue Per Share
8.461
Quarterly Revenue Growth
0.009
Return On Assets
(0.08)
Return On Equity
(1.51)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.